摘要 |
Novel non-steroidal compounds are provided that are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-?B activity including obesity, diabetes, inflammatory and immune diseases having the structure of formula (I): or enantiomers, diastereomers, or a pharmaceutically-acceptable salt, or hydrate, thereof, where X is -A<SUB>1</SUB>QA<SUB>2</SUB>-; Q is a bond, -C(=O)-, -OC(O)-, -C(=O)NR<SUB>5</SUB> <SUB>-</SUB>, |